Elevation Oncology, Inc. (ELEV)
USD 0.63
(-6.69%)
USD 0.63
(-6.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -56.18 Million | -85.48 Million | -30.16 Million | -12.29 Million | -5.45 Million |
| Net Income | -45.7 Million | -95.08 Million | -32.03 Million | -17.26 Million | -5.88 Million |
| Depreciation & Amortization | 39 Thousand | 27 Thousand | 18 Thousand | 15 Thousand | - |
| Deferred income taxes | 5.85 Million | - | -1.63 Million | 5.13 Million | - |
| Stock-based compensation | 3.33 Million | 3.2 Million | 1.57 Million | 52 Thousand | 13.5 Thousand |
| Change in working capital | -13.69 Million | 6.29 Million | 283 Thousand | 4.9 Million | 423 Thousand |
| Other non-cash items | -6.01 Million | 74 Thousand | 1.63 Million | -5.13 Million | -451 Thousand |
| Investing Cash Flow | 11.54 Million | -44.39 Million | - | -71 Thousand | - |
| Investments in PPE | - | -86 Thousand | - | -71 Thousand | - |
| Acquisitions | - | 44.31 Thousand | - | - | - |
| Investment purchases | -42.65 Million | -112.31 Million | - | - | - |
| Sales/Maturities of investments | 54.2 Million | 68 Million | - | - | - |
| Other Investing Activities | 11.54 Thousand | -44.31 Thousand | - | - | - |
| Financing Cash Flow | 47.97 Million | 29.51 Million | 97.05 Million | 90.02 Million | 7.19 Million |
| Debt repayment | - | -470 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -24 Thousand | -35 Thousand | - | - | - |
| Common Stock Issuance | 47.99 Million | 19 Thousand | 97.06 Million | 20 Thousand | 7.19 Million |
| Other Financing Activities | 47.99 Million | 30 Million | -11 Thousand | 90 Million | 10.78 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -5.85 Million | 711 Thousand | -30 Thousand | 5.21 Million | 460 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -7.83 Million | 5.57 Million | 313 Thousand | -319 Thousand | -37 Thousand |
| Cash at beginning of period | 45.91 Million | 146.28 Million | 79.4 Million | 1.74 Million | - |
| Cash at end of period | 49.25 Million | 45.91 Million | 146.28 Million | 79.4 Million | 1.74 Million |
| Capital Expenditure | - | -86 Thousand | - | -71 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 3.33 Million | -100.36 Million | 66.88 Million | 77.66 Million | 1.74 Million |
| Free Cash Flow | -56.18 Million | -85.56 Million | -30.16 Million | -12.36 Million | -5.45 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.88 Million | -10.46 Million | -10.7 Million | -7.89 Million | -45.7 Million | -10.63 Million |
| Depreciation & Amortization | -1.05 Million | 4000.00 | 10 Thousand | 10 Thousand | 39 Thousand | 9000.00 |
| Deferred income taxes | - | - | - | -3.43 Million | 5.85 Million | -204 Thousand |
| Stock-based compensation | 1.15 Million | 1.04 Million | 902 Thousand | 284 Thousand | 3.33 Million | 843 Thousand |
| Change in working capital | -840 Thousand | 1.44 Million | -605 Thousand | -4.27 Million | -13.69 Million | -3.54 Million |
| Other non-cash items | 5.24 Million | 906 Thousand | 1.81 Million | 3.14 Million | -6.01 Million | 180 Thousand |
| Investing Cash Flow | -2.87 Million | -37.66 Million | 20.7 Million | 6.56 Million | 11.54 Million | -38.11 Million |
| Investments in PPE | -8.2 Million | 8.2 Million | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -13.57 Million | -46.96 Million | - | -2.94 Million | -42.65 Million | -39.71 Million |
| Sales/Maturities of investments | 10.7 Million | 9.3 Million | 20.7 Million | 9.5 Million | 54.2 Million | 1.6 Million |
| Other Investing Activities | 8.2 Million | -37.66 Million | 20.7 Thousand | 6560.00 | 11.54 Thousand | -38.11 Thousand |
| Financing Cash Flow | 10 Thousand | 14.68 Million | 30.25 Million | -2000.00 | 47.97 Million | 27 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2000.00 | -16 Thousand | -26 Thousand | -2000.00 | -24 Thousand | -3000.00 |
| Common Stock Issuance | -937 Thousand | 14.71 Million | 30.42 Million | -47.99 Million | 47.99 Million | 30 Thousand |
| Other Financing Activities | 949 Thousand | -20 Thousand | -150 Thousand | 1.47 Million | 47.99 Million | 30 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 2.28 Million | -91 Thousand | -72 Thousand | -3.13 Million | -5.85 Million | -1.59 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1 Million | 1.53 Million | -533 Thousand | -1.14 Million | -7.83 Million | -1.95 Million |
| Cash at beginning of period | 59.44 Million | 90.63 Million | 49.25 Million | 54.87 Million | 45.91 Million | 106.32 Million |
| Cash at end of period | 48.2 Million | 59.44 Million | 90.63 Million | 49.25 Million | 49.25 Million | 54.87 Million |
| Capital Expenditure | -8.2 Million | 8.2 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | -53.32 Million | - | 53.32 Million |
| Net cash flow / Change in cash | -11.24 Million | -31.18 Million | 41.37 Million | -5.62 Million | 3.33 Million | -51.44 Million |
| Free Cash Flow | -16.58 Million | - | -9.57 Million | -12.18 Million | -56.18 Million | -13.35 Million |
THCOM
HOVS
TIPH
603028
AIRRF
FRMEP